Memorial Sloan Kettering Innovations in Personalized Oncology: A Case-Based Approach

Memorial Sloan Kettering Innovations in Personalized Oncology: A Case-Based Approach is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held on May 04, 2018 at Mortimer B. Zuckerman Research Center, New York, United States of America.

The target audience for this medical event is Breast Medical Oncology, Colon & Rectal Surgery , Gynecologic Oncology, Head and Neck Oncology, Lymphoma, Obstetrics & Gynecology, Pediatric Oncology, Thoracic Medical Oncology, Urology includes physicians, advanced practice providers, nurses, allied health professionals and administrators looking for innovative, disease-specific oncology content set within multidisciplinary case discussions. This CME Conference has been approved for a maximum of 7 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conference Summary:
Research advances are leading at an unprecedented rate to opportunities for greater personalization of management approaches for patients with cancer and the promise of related improvements in disease-control and patient-reported outcomes. A challenge facing clinical practitioners, oncology care teams and healthcare systems is the identification and timely integration of these important innovations, often developed at specialty centers, into day-to-day clinical practice in the community setting and closer to where patients live.

A central goal of this CME course is to help busy oncologists and other oncology care team members acquire clinically-relevant, cutting-edge knowledge and translate these innovations into best practices, using lessons learned within the MSK Cancer Alliance and highlighting the personalized approach to cancer care taken by MSK and its Alliance Members.

Incorporating a case-based format that utilizes real-life, clinical scenarios, the moderator of each multidisciplinary expert panel will use audience response to examine key decision points and guide targeted commentary and presentations from panel members that include oncologists and other oncology care team members.

Panels will cover eight different diseases, both rare and more common, and address a spectrum of management issues across the care continuum. Immunotherapy, from evolving predictors of response to symptom management for these new agents, will be the focus of two keynote talks. After this course, attendees will be better able to tailor care to meet the unique needs of their patients and appreciate the role of dynamic partnerships among providers to optimally personalize and improve outcomes of cancer care.

Conference Objectives:
• Evaluate the potential utility of the covered developments and advances in current oncology practice.
• Outline and evaluate the supporting evidence for these developments and advances.
• Appreciate the appropriate clinical settings to apply the reviewed technologies and therapies.
• Incorporate appropriately these novel strategies into patient care.
• Understand how Alliance relationships can facilitate bi-directional learning and improve outcomes of care.

3rd Annual MSK Cancer Alliance Symposium
The MSK Cancer Alliance is a collaborative relationship, leveraging bi-directional learning for mutual improvement. It is composed of MSK and a small number of high-quality, community healthcare systems seeking to be centers of excellence in their respective communities with a focus on clinical research and a culture of improvement. The MSK Cancer Alliance strives to bridge the knowledge gaps between an academic comprehensive cancer center such as MSK and community hospitals in order to help facilitate the delivery of high-quality cancer care at the community level, an important need since most cancer care is delivered in the community setting.